Status:
COMPLETED
Papillomavirus Post-THErapeutique
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
High Grade Intraepithelial
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
In recent years, studies have multiplied to demonstrate the value of performing an HPV test compared to a cervical smear test (CSP) in cervical cancer screening but also in the follow-up of surgical r...
Detailed Description
For research purposes, on the day of surgery, specimens at the squamocolumnar junction intraoperatively before and after surgical removal of the HGILs will be taken. Then at follow-up visits at M1 (ca...
Eligibility Criteria
Inclusion
- Women
- Over 18 years old
- High-grade intraepithelial lesion (WHO classification)
- Intracervical neoplasms 2 and 3, Richart classification
- Collection of written, free and informed consent
- Affiliation to a social security scheme
Exclusion
- Immunocompromised patients (HIV infection, or iatrogenic)
- Patient with a history of treated HGIL
- Patient who does not understand French
- Patient unable to express consent
Key Trial Info
Start Date :
December 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05434338
Start Date
December 23 2022
End Date
December 23 2024
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service : Chirurgie et oncologie gynécologique et mammaire, Hôpital Pitié Salpêtrière
Paris, France, 75013